Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
09/2002
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451819 Pyrrolidine-3-yl-sulfanyl, or sufonyl or sufinyl derivatives used in the treatment of neurodegenerative diseases
09/17/2002US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/17/2002US6451727 Prepared from chiral amino alcohols; suitable for assymetric catalysis; for transfer hydrogenation of ketones and imines; enantiomorphs; purity; efficiency
09/17/2002CA2278878C Very large scale immobilized peptide synthesis
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002US20020128486 Phosphinite-oxazolines and metal complexes
09/12/2002US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/12/2002US20020128308 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect.
09/12/2002US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action
09/12/2002US20020128269 Piperazine derivatives
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/12/2002CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/11/2002EP1237953A2 Polymerization of olefins
09/11/2002EP1237874A2 Selective neurokinin antagonists
09/11/2002EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
09/11/2002EP1237551A1 Pharmaceutical formulations containing zolmitriptan
09/11/2002EP0912504B1 Oxazolidine ester
09/11/2002CN1368961A Compounds for modulation of PPAP gamma activity
09/11/2002CN1090620C New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them
09/10/2002US6448409 Acylation of an 2-oxazolidineselone with an alkyl acylhalide and hydroxylation with an aldehyde
09/10/2002US6448406 Improved process for preparation of terfenadine carboxylic acid metabolite and carebastine derivatives; histamine h1 receptor blocking and calcium antagonists; respiratory, allergic, and cardiovascular disease states
09/10/2002US6448399 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-n-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide.
09/10/2002US6448396 Compounds useful as neuro-protective agents
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/10/2002US6448278 Antiscarring agent
09/10/2002US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?)
09/10/2002US6448201 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation, and their use as herbicides and plant growth regulators
09/06/2002WO2002068380A1 Synthetic excitatory amino acids
09/06/2002WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/06/2002WO2002043716A3 Method for regulating prostate gland volume with insulin sensitizers
09/06/2002WO2002036580A3 Benzoxazole lpaat- beta inhibitors and uses thereof
09/06/2002WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance
09/05/2002US20020123512 Pharmaceutical composition
09/05/2002US20020123498 For inhibiting transport protein; therapy
09/05/2002DE10110325A1 Phenylderivate 2 Phenyl derivatives 2
09/04/2002EP1235816A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators
09/04/2002EP1235795A1 Process for the preparation of sulfamides
09/04/2002CN1367785A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group
09/04/2002CN1367780A Oxazolidinones and their preparing method and use thereof
09/04/2002CN1090184C Heterocyclic compounds and preparing method thereof
09/03/2002US6444827 From beta-methyl l-aspartate via chemical intermediate; efficiency; antidiabetic agents
09/03/2002US6444825 Chemical intermediate for taxol
09/03/2002US6444824 Antiserotonine agents; side effect reduction
09/03/2002US6444813 Mixing linezolid of an >98% enantomeric purity in a solvent at >80 degrees; separating a crystal (ii) of >99% purity; analysis by the powder x-ray diffraction spectrum/infrared spectrum as a mineral oil mull; bactericides; stability
09/03/2002US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/2002CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors
08/2002
08/29/2002WO2002066449A2 Process for the preparation of mesylates of piperazine derivatives
08/29/2002WO2002066448A1 Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120152 Aminoaryl oxazolidinone N-oxides
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020119979 Cancer therapy
08/29/2002US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
08/29/2002US20020119960 Drug resistance therapy
08/28/2002EP1234827A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234826A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234825A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234824A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234823A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002EP1233962A2 Novel heterocyclic compounds and their use as medicines
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002CN1089761C Sidechain-bearing texanes and its preparing process
08/27/2002US6441195 Substituted sulphonylamino(thio) carbonyl compounds
08/27/2002US6441189 Process for the preparation of matrix metalloproteinase inhibitors
08/27/2002US6441188 Aminoaryl oxazolidinone N-oxides
08/27/2002US6441185 Method for producing thiazolidinediones, and new thiazolidinediones
08/27/2002US6441184 Such as n-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type ii diabetes
08/27/2002US6441173 Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6441013 5-ht6 receptor antagonists for treating central nervous system disorders
08/27/2002US6441012 Chemical compounds
08/27/2002US6441005 Oxazolidinone compounds and compositions, and methods of using the same
08/27/2002US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
08/27/2002US6440667 Analysis of target molecules using an encoding system
08/22/2002WO2002064577A2 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
08/22/2002WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/22/2002WO2002064558A2 Oxazole derivatives, their preparation and their use as cytokine inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance
08/22/2002US20020115853 6-(3-nitrophenyl)-3H-benzooxazol-2-one for example; contraceptives, treating hormone dependent tumors, endometriosis; progesterone receptor agonists and antagonists
08/22/2002US20020115701 Have antipyretic action, analgesic action, antiinflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2; ketomethylene intermediates
08/22/2002US20020115669 Treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy.
08/22/2002CA2438105A1 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
08/22/2002CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/21/2002EP1231939A2 Oncolytic combinations for the treatment of cancer
08/20/2002US6437146 Mesangial proliferative glomerulonephritis
08/20/2002US6437145 Reacting n-protected aminodicarboxylic acids with a dehydrating agent to form cyclic anhydrides which are reacted with carbonyl compounds; for the alpha-selective production of esters or amides of dicarboxylic amino acids
08/20/2002US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors